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Somatostatin (SRIH), a regulatory peptide, is produced by neu-
roendocrine, inflammatory, and immune cells in response to
ions, nutrients, neuropeptides, neurotransmitters, thyroid and
steroid hormones, growth factors, and cytokines (P a t e l,
1999). Somatostatin has been demonstrated to play an impor-
tant role as an endogenous inhibitor of cell proliferation in var-
ious normal and neoplastic tissues (S c h a l l y, 1988). The di-
verse biological effects of SRIH are mediated by a family of
seven transmembrane domain G-protein-coupled receptors that
comprise five distinct subtypes, 1-5 (sst1-5) (P a t e l, 1999). The
pituitary is the main target for physiological actions of SRIH,
and different amounts of sst are present in the pituitary secretary
cells. Somatostatin and its analogs are now being used for the
treatment of different human tumors (R e u b i and L a i s s u e,
1995). 
It therefore seemed worthwhile to examine the effect of
SRIH-14 on morphofunctional parameters of pituitary cortico-
tropes (ACTH cells). 
Adult male Wistar rats were bred in the Institute for Bio-
logical Research in Belgrade, Serbia. The rats were housed in a
controlled environment at 22±2°C under conditions of a 12 h of
light/12 h of darkness schedule. The animals were allowed food
and water ad libitum. Food for laboratory rats was prepared in
the Veterinary Institute (Subotica, Serbia). Experimental proto-
cols were ones approved by the Local Animal Care Committee.
They conformed to the recommendations provided in the
“Guide for the Care and Use of Laboratory Animals” (1996,
National Academy Press, Washington, D.C.). Adult male rats
were divided into four experimental groups. Rats of the first
group were injected s.c. twice a day with 20 mg of SRIH-14 per
100 g b. w. for 5 consecutive days (multiple treatment). Males
of the second group received 20 mg of SRIH-14 per 100 g b.w.
for 28 consecutive days (chronic treatment). The control groups
(third and fourth groups) received physiological saline for 5 or
28 consecutive days. All animals were sacrificed by decapita-
tion under deep anesthesia 12 h after the last injection, at which
time pituitary glands were excised. Pituitary glands were fixed
in Bouin’s solution, embedded in paraffin, and sliced through
three tissue levels of the pars distalis. Five-mm-thick immuno-
cytochemically stained pituitary sections were used for mor-
phometric examinations (M i l o š e v i ć et al., 1994). The cell
volumes (Vc), nuclear volumes (Vn), and volume densities (Vv)
of ACTH cells were estimated under a light microscope (Carl
Zeiss, Germany) at 1000x magnification using the M42 multi-
purpose test system (W e i b e l, 1979). The volumes of ACTH-
positive cells are expressed in µm3. Volume densities are pre-
sented as percentages (%) of total pituitary cells. Plasma levels
of ACTH were determined by the chemiluminiscent enzyme
immunometric assay IMMULITE ACTH (DPC, Los Angeles).
The Duncan test was used for statistical analyses.
After multiple treatment, the absolute weights of the pitui-
tary gland, volume of ACTH cells, and volume density de-
creased insignificantly (p>0.05) by 8, 3 and 3%, respectively, in
comparison with the controls (Table 1). In animals chronically
treated with SRIH-14, absolute weight of the pituitary gland
and volume density of ACTH cells decreased significantly
(p<0.05) by 22 and 11%, respectively, in comparison with the
controls (Table 1). The volume of ACTH cells and their nuclei
changed insignificantly (p>0.05) in comparison with the corre-
sponding controls (Table 1). The plasma levels in both treated
EFFECTS OF SRIH-14 ON ACTH CELLS IN MALE RATS. Svetlana Trifunović, V. Ajdžanović, B.
Filipović, Milka Sekulić and Verica Milošević. Siniša Stanković Institute for Biological Research, 11060
Belgrade, Serbia
Key words: somatostatin, ACTH cells, male rats
UDC 577.17 : 577.175.3 : 599
43P
Arch. Biol. Sci., Belgrade, 59 (3), 43P-44P, 2007. DOI:10.2298/ABS070343PT
Table 1. Effects of multiple and chronic treatment with SRIH-14 on absolute pituitary weight, volume density of ACTH cells, and volumes of ACTH
cells and their nuclei in male rats. (mean ± SD; n=5); *p < 0.05 vs. controls
 
Groups Pituitary weight (mg) 
Volume 
density of 
ACTH (%) 
 
Volume of 
ACTH cells 
(mm3) 
Volume nuclei 
of ACTH 
(mm3) 
C 10.3 ± 1.2 17 ± 1 1056 ± 11 147± 11 Multiple 
treatment SRIH-14 9.5 ± 2.1 16.5 ± 1.5 1024 ± 91 143± 10 
C 9 ± 0.1 17 ± 1.3 1044 ± 40 144± 3 Chronic 
treatment SRIH-14 7 ± 1* 16.5 ± 1.5 * 996± 55 141± 4 
 
groups decreased insignificantly (p>0.05) (Fig. 1) in relation to
the corresponding controls.
The results of this experiment suggest that multiple and
chronic administration of SRIH-14 causes decrease in morpho-
metric parameters of ACTH cells and lowering of the ACTH
blood level. Statistically significant reductions of absolute pitu-
itary weights and volume density of the ACTH cells were ob-
served in the case of chronic treatment with SRIH-14. An earli-
er study showed that decrease of absolute pituitary weights
might be a result of decrease in volume density of somatotropes
and lactotropes, which together comprise more than 60% of pi-
tuitary cells (M i l o š e v i ć et al., 1998). The absence of sig-
nificant changes of stereological parameters after both treat-
ments can be attributed to low expression of sst in pituitary
ACTH cells (O ¢ C a r r o l l and  K r e m p e l s, 1995). Up-
regulation of sst can account for greater reduction of stereolog-
ical parameters after chronic than after multiple treatment
(H u k o v i c et al., 1996). 
It can be concluded that s.c. injection of SRIH-14 can in-
duce a low degree of changes in morphofunctional characteris-
tics of ACTH cells.
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Fig. 1. Effects of multiple and chronic treatments with SRIH-14 on
blood ACTH concentrations in male rats (mean ± SD; n=5).
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